Diagnostic value of monocyte chemoattractant Protein-1, soluble mannose receptor, Presepsin, and Procalcitonin in critically ill children admitted with suspected sepsis

Table 1 Demographic and clinical data of the studied groups

		Sepsis (I)	SIRS (II)	Control (III)	P value
		N = 58	N = 24	N = 50	Among 3 groups	I vs II	I vs III	II vs III
Age (years)(Mean ± SD)		2.4 ± 1	2.9 ± 1.2	3 ± 0.9	0.087	0.113	0.233	0.768
Sex					0.507	0.350	0.743	0.246
M		40(69%)	19(79.2%)	33(66%)
F		18(31%)	5(20.8%)	17(34%)
LOS (days) (Mean ± SD)		(2-9) 5.5 ± 1.9	(2-8) 4.8 ± 1.8			0.102
ventilatory Support	No	33(56.9%) 25(43.1%)	13(54.2%) 11(45.8%)			0.821
ventilatory Support	Yes	33(56.9%) 25(43.1%)	13(54.2%) 11(45.8%)			0.821
GCS	> 8	38(65.5%) 20(34.5%)	12(50%) 12(50%)			0.190
GCS	< 8	38(65.5%) 20(34.5%)	12(50%) 12(50%)			0.190
Inotropic drug	No	34(58.6%) 24(41.4%)	12(50%) 12(50%)			0.474
Inotropic drug	Yes	34(58.6%) 24(41.4%)	12(50%) 12(50%)			0.474
Outcome	Survivals	33(56.9%) 25(43.1%)	15(62.5%) 9(37.5%)			0.603
Outcome	Non-survivals	33(56.9%) 25(43.1%)	15(62.5%) 9(37.5%)			0.603

One way ANOVA test for parametric quantitative data (expressed as mean ± SD) between the three groups followed by post hoc Tukey’s analysis between each two groups
Chi square test for qualitative data between groups
Significant level at P value < 0.05
LOS Length of Stay, GCS Glasgow Coma Scale

ISSN: 1471-2431